-
1
In Silico Design of Dual Estrogen Receptor and Hsp90 Inhibitors for ER-Positive Breast Cancer Through a Mixed Ligand/Structure-Based Approach
Published 2024-12-01Subjects: Get full text
Article -
2
Design, synthesis and biological studies of new isoxazole compounds as potent Hsp90 inhibitors
Published 2024-11-01Subjects: Get full text
Article